Although patient selection is critical, TORS offers a minimally invasive option to access oropharyngeal tumors through the mouth.
Which research results from the American Society for Radiation Oncology’s 2019 annual meeting are the most interesting or clinically relevant? The staff of Cleveland Clinic Cancer Center’s Department of Radiation Oncology picks their Top 10.
New clinical practice guidelines from ASCO offer a systematic, evidence-based approach to managing the neck in squamous cell carcinomas of the oral cavity and of the oropharynx.
Two recent studies demonstrate the safety of sparing the submandibular and other salivary glands when performing radiation therapy on patients with head and neck cancers.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Distant metastases may occur later and in unexpected sites in patients with HPV-positive oral cancer, indicating that new surveillance strategies may be needed. These findings reflect Cleveland Clinic’s experience over 18 years.
The rise of oropharyngeal cancer worldwide is attributable to a corresponding rise in human papillomavirus-related squamous cell carcinoma. Treatments must be altered accordingly.
An increasing share of oropharyngeal cancers are due to HPV infection, which is translating to better treatment response. And emerging findings suggest a bacterial connection with oral cancers.